Summary Nanobiotix SA (Nanobiotix) is a nanomedicine company that develops tools for local treatment of cancer. The company provides products such as NBTXR3, NBTX IV and TOPO NBTX. Its NBTXR3 nanoparticles are designed for direct injection into the tumor. Nanobiotix’s NBTX-IV nanoparticles are designed for intravenous injection. The company’s NBTX-TOPO nanoparticles is a gel to be applied during surgery after removal of the tumor. It also develops other nanomedicine programs such as nanoMag, magnetic particles for the treatment and diagnosis of cancer; and nanoPDT. The company operates in the US and France. Nanobiotix is headquartered in Paris, France. Nanobiotix SA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types,... Research Beam Model: Research Beam Product ID: 2637874 250 USD New
Nanobiotix SA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Nanobiotix SA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : October   2017
  • Pages : 33
  • Publisher : GlobalData
 
 
 
Summary

Nanobiotix SA (Nanobiotix) is a nanomedicine company that develops tools for local treatment of cancer. The company provides products such as NBTXR3, NBTX IV and TOPO NBTX. Its NBTXR3 nanoparticles are designed for direct injection into the tumor. Nanobiotix’s NBTX-IV nanoparticles are designed for intravenous injection. The company’s NBTX-TOPO nanoparticles is a gel to be applied during surgery after removal of the tumor. It also develops other nanomedicine programs such as nanoMag, magnetic particles for the treatment and diagnosis of cancer; and nanoPDT. The company operates in the US and France. Nanobiotix is headquartered in Paris, France.

Nanobiotix SA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanobiotix SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nanobiotix SA, Medical Devices Deals, 2011 to YTD 2017 9
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanobiotix SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Nanobiotix Enters Into Co-Development Agreement With National Cancer Institute For NBTX-IV 11
Nanobiotix Enters Into Co-Development Agreement With Thomas Jefferson University For Nbtxr3 12
Licensing Agreements 13
Pharmaengine Enters Into Licensing Agreement With Nanobiotix For NBTXR3 13
Equity Offering 15
Nanobiotix Raises USD26.8 in Private Placement of Shares 15
Nanobiotix Announces Exercise of Warrants 16
Nanobiotix Raises USD23.5 Million in Private Placement of Shares 17
Nanobiotix Raises USD12.8 Million in Private Placement of Shares 18
Nanobiotix Completes IPO For 18 Million 19
Nanobiotix SA - Key Competitors 21
Nanobiotix SA - Key Employees 22
Nanobiotix SA - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 31, 2017: NANOBIOTIX half year results for the six months ended 30 June 2017 24
Jul 12, 2017: Nanobiotix Revenues for the 2nd Quarter of 2017 25
May 15, 2017: Nanobiotix revenue for the 1st quarter of 2017 26
Aug 31, 2016: Nanobiotix half year results for the six months ended 30 June 2016 27
Jul 13, 2016: Nanobiotix revenue for Q2 2016 29
Apr 29, 2016: Nanobiotix: 2015 Annual Results 30
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
Nanobiotix SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanobiotix SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanobiotix SA, Deals By Therapy Area, 2011 to YTD 2017 8
Nanobiotix SA, Medical Devices Deals, 2011 to YTD 2017 9
Nanobiotix SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanobiotix Enters Into Co-Development Agreement With National Cancer Institute For NBTX-IV 11
Nanobiotix Enters Into Co-Development Agreement With Thomas Jefferson University For Nbtxr3 12
Pharmaengine Enters Into Licensing Agreement With Nanobiotix For NBTXR3 13
Nanobiotix Raises USD26.8 in Private Placement of Shares 15
Nanobiotix Announces Exercise of Warrants 16
Nanobiotix Raises USD23.5 Million in Private Placement of Shares 17
Nanobiotix Raises USD12.8 Million in Private Placement of Shares 18
Nanobiotix Completes IPO For 18 Million 19
Nanobiotix SA, Key Competitors 21
Nanobiotix SA, Key Employees 22
Nanobiotix SA, Subsidiaries 23
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter